Imaging study solves a long-standing gap in metastatic breast cancer research and care

A prospective, multicenter cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) has validated an improved method for predicting treatment benefits in patients with hormone receptor-positive (HR+) metastatic breast cancer…

Continue Reading

News Source: medicalxpress.com